Kleeman J M, Moore R W, Peterson R E
Environmental Toxicology Center, University of Wisconsin, Madison 53706.
Toxicol Appl Pharmacol. 1990 Oct;106(1):112-25. doi: 10.1016/0041-008x(90)90111-7.
The mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment decreases testosterone (T) secretion without significantly altering plasma luteinizing hormone (LH) concentrations was investigated. Testes from sexually mature Sprague-Dawley rats dosed 7 days earlier with 100 micrograms TCDD/kg secreted 30-75% less T than did testes from control rats when perfused in vitro with the LH analog human chorionic gonadotropin (hCG). This decrease confirms that testicular responsiveness to LH, the hormone which regulates T secretion in vivo, is impaired by TCDD treatment. Because TCDD also reduced intratesticular T content, the decrease in T secretion is due to an inhibition of T synthesis rather than to a failure of the secretion process. These effects of TCDD are not secondary to undernutrition, because perfused testes from feed-restricted control rats were fully hCG responsive. TCDD treatment neither increased the hCG-stimulated secretion of any T precursor nor significantly decreased the efficiency with which testes converted the pregnenolone (PREG) they synthesized into T (PREG is the initial steroidogenic intermediate). In addition, TCDD did not inhibit T secretion when steroidogenesis was supported by exogenous PREG at approximately the in vivo rate. We conclude that TCDD does not inhibit the conversion of PREG to T. The inhibition of T biosynthesis must instead result from an inhibition of PREG formation. The finding that TCDD treatment substantially decreased the rate at which hCG-perfused testes secreted PREG and its metabolites (a decrease seen across all hCG concentrations) confirms this conclusion. This inhibition of LH/hCG-stimulated PREG formation by TCDD must be due to a reduction in the activity of the enzyme which converts cholesterol to PREG (cytochrome P450scc), and/or an impairment in the multistep process responsible for mobilizing cholesterol to this enzyme.
研究了2,3,7,8-四氯二苯并对二恶英(TCDD)处理降低睾酮(T)分泌而不显著改变血浆促黄体生成素(LH)浓度的机制。性成熟的Sprague-Dawley大鼠在7天前经100微克TCDD/千克剂量处理,当在体外与LH类似物人绒毛膜促性腺激素(hCG)一起灌注时,其睾丸分泌的T比对照大鼠的睾丸少30 - 75%。这种减少证实了TCDD处理会损害睾丸对LH的反应性,LH是体内调节T分泌的激素。由于TCDD也降低了睾丸内T的含量,T分泌的减少是由于T合成受到抑制,而不是分泌过程的失败。TCDD的这些作用并非继发于营养不足,因为来自限食对照大鼠的灌注睾丸对hCG有充分反应。TCDD处理既没有增加hCG刺激的任何T前体的分泌,也没有显著降低睾丸将它们合成的孕烯醇酮(PREG)转化为T的效率(PREG是初始的类固醇生成中间体)。此外,当以大约体内速率通过外源性PREG支持类固醇生成时,TCDD并没有抑制T分泌。我们得出结论,TCDD不会抑制PREG向T的转化。相反,T生物合成的抑制必定是由于PREG形成受到抑制。TCDD处理显著降低了hCG灌注睾丸分泌PREG及其代谢物的速率(在所有hCG浓度下均可见这种降低)这一发现证实了这一结论。TCDD对LH/hCG刺激的PREG形成的这种抑制必定是由于将胆固醇转化为PREG的酶(细胞色素P450scc)的活性降低,和/或负责将胆固醇转运至该酶的多步骤过程受到损害。